Results 71 to 80 of about 134,137 (295)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

A systematic review of myasthenia gravis complicated with myocarditis

Brain and Behavior, 2021
Among many of the autoimmune diseases observed in patients with myasthenia gravis (MG), myocarditis is one of the most critical. The goal of this review is to systematically describe and investigate the characteristics of MG complicated with myocarditis.
Wei Cheng, Tian Sun, Cong Liu, Zijing Zhou, Jiaxi Duan, Yiyang Zhao, Min Yang, Ping Chen   +7 more
doaj   +1 more source

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis

Journal for ImmunoTherapy of Cancer, 2021
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other ...
Anju Nohria, Alexander R Lyon, Stephane Ederhy, Franck Thuny, Michael Mahmoudi, Magid Awadalla, Dahlia Banerji, Merna Armanious, Dipti Gupta, Sarju Ganatra, Paaladinesh Thavendiranathan, Gagan Sahni, Ryan Sullivan, Lili Zhang, Tomas G Neilan, Daniel A Zlotoff, Malek Z O Hassan, Amna Zafar, Raza M Alvi, Syed S Mahmood, Carol L Chen, Ana Barac, Maeve Jones-O'Connor, Sean P Murphy, Brian J Forrestal, Michael C Kirchberger, Otavio R Coelho-Filho, Muhammad A Rizvi, Anant Mandawat, Carlo G Tocchetti, Sarah Hartmann, Hannah K Gilman, Eduardo Zatarain-Nicolás, Lucie M Heinzerling, Justine V Cohen, John Groarke, Michael G Fradley   +36 more
doaj   +1 more source

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

Nature Communications, 2022
Cases of myocarditis and pericarditis have been reported following the receipt of Covid-19 mRNA vaccines. As vaccination campaigns are still to be extended, we aimed to provide a comprehensive assessment of the association, by vaccine and across sex and ...
S. Le Vu, M. Bertrand, Marie-Joëlle Jabagi, Jérémie Botton, J. Drouin, B. Baricault, Alain Weill, R. Dray-Spira, Mahmoud Zureik   +8 more
semanticscholar   +1 more source

Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin

European Heart Journal, 2020
BNP 139ng/L.
Hongde Hu, Fenglian Ma, Xin Wei, Yuan Fang   +3 more
semanticscholar   +1 more source

Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection

JAMA cardiology, 2021
This cohort study assesses the prevalence of myocarditis in athletes with COVID-19 and compares screening strategies for safe return to play.
C. Daniels, S. Rajpal, J. Greenshields, G. Rosenthal, Eugene H. Chung, M. Terrin, J. Jeudy, S. Mattson, I. Law, J. Borchers, R. Kovacs, J. Kovan, S. Rifat, J. Albrecht, A. Bento, L. Albers, D. Bernhardt, Carly Day, S. Hecht, A. Hipskind, J. Mjaanes, David Olson, Yvette L. Rooks, E. Somers, M. Tong, Jeffrey Wisinski, Jason P. Womack, Carrie Esopenko, C. Kratochvil, L. Rink   +29 more
semanticscholar   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Viral Myocarditis: Classification, Diagnosis, and Clinical Implications

Frontiers in Cardiovascular Medicine, 2022
Myocarditis is an inflammatory disease of the myocardium with focal or diffuse involvement. Viral infections are the most common cause of myocarditis, especially in Western countries.
Fabiola B. Sozzi, Elisa Gherbesi, Andrea Faggiano, Eleonora Gnan, Alessio Maruccio, Marco Schiavone, Laura Iacuzio, Stefano Carugo   +7 more
doaj   +1 more source

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents [PDF]

, 2022
Dror Mevorach, Emilia Anis, Noa Cedar, Tal Hasin, Michal Bromberg, Lital Goldberg, Elchanan Parnasa, Rita Dichtiar, Yael Hershkovitz, Nachman Ash, Manfred S. Green, Lital Keinan-Boker, Sharon Alroy‐Preis   +12 more
openalex   +1 more source

Myocardial Injury Pattern at MRI in COVID-19 Vaccine–Associated Myocarditis

Radiology, 2022
Background There are limited data on the pattern and severity of myocardial injury in patients with COVID-19 vaccination–associated myocarditis. Purpose To describe myocardial injury following COVID-19 vaccination and to compare these findings to other ...
Matteo Fronza, P. Thavendiranathan, V. Chan, G. Karur, J. Udell, R. Wald, Rachel Hong, Kate Hanneman   +7 more
semanticscholar   +1 more source